About BCU CME Meetings Special Editions Meet The Professors Patterns of Care Conference Partnerships Patient Projects Other Tumor Types About us

Editor's Note
Neil Love, MD
50 years of innovation and achievement
- Select Publications

Co-Chair
Norman Wolmark, MD
Chairman, National Surgical
Adjuvant Breast and Bowel
Project; Chairman
Department of Human Oncology
Allegheny General Hospital
Pittsburgh, Pennsylvania
Professor of Human Oncology
Drexel University
College of Medicine
Philadelphia, Pennsylvania

Faculty  
Vincent T DeVita Jr, MD
Amy and Joseph Perella
Professor of Medicine
Yale University School of Medicine
Yale Cancer Center
Professor of Epidemiology and
Public Health
Yale School of Public Health
New Haven, Connecticut

Bernard Fisher, MD
Distinguished Service Professor
University of Pittsburgh
Department of Surgery
Past Chairman and Scientific Director
National Surgical Adjuvant Breast and
Bowel Project (NSABP)
Pittsburgh, Pennsylvania

Charles E Geyer Jr, MD
Director of Medical Affairs
National Surgical Adjuvant Breast
and Bowel Project
Vice-Chair
Department of Human Oncology
Allegheny General Hospital
Pittsburgh, Pennsylvania

Eleftherios P Mamounas, MD, MPH
Associate Professor of Surgery
Northeastern Ohio Universities
College of Medicine
Medical Director
Aultman Cancer Center
Canton, Ohio

Kathy D Miller, MD
Sheila D Ward Scholar of Medicine
Associate Professor of Medicine
Indiana University Simon Cancer
Center
Indianapolis, Indiana

Mark D Pegram, MD
Director for Translational
Research
Program, Braman Family
Breast Cancer
Research Institute
UM Sylvester
Comprehensive Cancer Center
Miami, Florida

Peter M Ravdin, MD, PhD
Research Professor of Biostatistics
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Sandra M Swain, MD
Medical Director
Washington Cancer Institute
Washington Hospital Center
Professor of Medicine
Georgetown University
Washington, DC

TOPICS

Adjuvant anthracyclines for HER2-positive or HER2-negative disease
• BCIRG 006 trial
• US Oncology trial of TC (docetaxel/cyclophosphamide) versus AC

Clinical trials of adjuvant bevacizumab for HER2-negative disease
• “TIC-TAC-TOE” trial
• NSABP-C-08 trial
• ECOG-E5103 trial

New research strategies being evaluated for HER2-positive disease
• BETH trial
• ALTTO trial

New research strategies for HER2-negative disease
• NSABP-B-40 neoadjuvant trial
• NSABP-B-31 analysis of HER2-low tumors

Genomic-based predictors of prognosis
• Oncotype DX® assay
• MammaPrint® assay
• TAILORx trial

New strategies for ER-positive disease
• ABCSG-12 trial
• NSABP-B-42 trial, MA17 extension trial

- Select Publications


A CME Audio Series and Activity | Faculty Disclosures | Editor's Office

 





Media Center
PDF
Media Center
Podcast
Previous Editions
Home Terms and Conditions of Use and General Disclaimer
Copyright © 2008 Research To Practice. All Rights Reserved